Virax Biolabs Group Ltd Increase Decrease In Cash And Cash Equivalents
Virax Biolabs Group Ltd (VRAX) reported Increase Decrease In Cash And Cash Equivalents of $639.70 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-07-02
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|
| 2025-03-31 | $639.70K 20-F · filed 2025-07-02 |
| 2024-03-31 | -$5.76M 20-F · filed 2025-07-02 |
| 2023-03-31 | $9.33M 20-F · filed 2025-07-02 |
| 2022-03-31 | $4.13K 20-F · filed 2024-08-20 |
| 2021-03-31 | -$4.99K 20-F · filed 2022-08-12 |